SUBSCRIBE
SUBSCRIBE

Vertex Pharmaceuticals

NEWS
Pharm Country
2 Views On Vertex Stock: Short Term Vs. Long Term
September 12, 2017
 · 
1 min read
Why Booming Vertex is on Its Way to Becoming Gilead's Mini-Me
Drug Development
Vertex’s Terminated Phase II CF Trial Was Planned
September 12, 2017
 · 
2 min read
Pharm Country
Vertex May Be Turning Some Major Corners
August 14, 2017
 · 
1 min read
Pharm Country
For Vertex, Can One Billion-Dollar Breakthrough Beget Another?
August 9, 2017
 · 
1 min read
Why Booming Vertex is on Its Way to Becoming Gilead's Mini-Me
Drug Development
Vertex Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials
July 19, 2017
 · 
3 min read
Analyst: 3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven
Deals
3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven
July 5, 2017
 · 
3 min read
Deals
Why Vertex Could Still Be Gilead’s Best Takeover Option
June 30, 2017
 · 
1 min read
Genetown
3 Biotechs That May Be Gearing Up For A Vertex-Like Run
June 9, 2017
 · 
1 min read
Why Booming Vertex is on Its Way to Becoming Gilead's Mini-Me
Policy
Tension Rises Between Vertex and Its Religious Investors Over Lobbying Disclosures
April 19, 2017
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Biotech Beach
Claire’s Place Foundation Receives Grant From Vertex
June 22, 2016
 · 
3 min read
Drug Development
Vertex Announces Presentations Of Data For KALYDECO (Ivacaftor) And ORKAMBI® (Lumacaftor/Ivacaftor) At European Cystic Fibrosis Society (ECFS) Conference
June 10, 2016
 · 
10 min read
Genetown
Vertex To Present At The Goldman, Sachs & Co. Healthcare Conference On June 7
June 1, 2016
 · 
1 min read
Policy
Vertex Release: FDA Accepts For Priority Review Supplemental New Drug Application For The Use Of ORKAMBI (Lumacaftor/Ivacaftor) In Children With Cystic Fibrosis Ages 6 To 11 Who Have Two Copies Of The F508del Mutation
May 31, 2016
 · 
9 min read
Deals
Spero Acquires Novel Gyrase Inhibitors From Vertex
May 25, 2016
 · 
1 min read
Business
Vertex Reports First Quarter 2016 Financial Results
April 28, 2016
 · 
1 min read
Business
Enterome In-Licenses Novel Compounds From Vertex To Treat Microbiome-Related Inflammatory Bowel Diseases
April 18, 2016
 · 
2 min read
Business
Vertex To Announce First Quarter 2016 Financial Results On April 27
April 15, 2016
 · 
1 min read
Genetown
Vertex To Present At The Barclays Healthcare Conference On March 15
March 11, 2016
 · 
1 min read
Business
Hovione And Vertex Partner In Continuous Manufacturing
March 10, 2016
 · 
2 min read
Load More